Susanne Dam Nielsen, Md, Dmsc

This study tests whether a daily antibiotic (pivmecillinam) can prevent serious bloodstream infections in 150 kidney transplant recipients who are at high risk. Participants will receive either the antibiotic or a placebo for six months after their transplant. The goal is to redu…